The forward P/E of 17.20 sitting above the trailing 16.22 implies consensus is modeling a year-over-year EPS decline rather than growth, which sits awkwardly beside a PEG of 1.61 versus BOOT's 0.53. The 6.89x price-to-book against an ROIC of 2.5% suggests the book premium is only defensible if the market expects the 13.2%-to-7.9% operating margin slide to reverse. Relative to CASY at 36.50x earnings and ORLY at 30.28x, TSCO looks cheap on P/E at 11.87x EV/EBITDA, but those peers compound ROIC of 12.0% and 37.2% respectively, so the multiple gap may simply reflect a structural quality discount rather than a value opportunity.

Gross margin of 33.0% compares with 37.4% in 2025Q3, a roughly 440 basis point give-back that is unlikely to be explained by the May weather disruption alone, and the 25.6% reading in 2025Q4 still warrants scrutiny of vendor allowance timing and inventory valuation. Because SG&A grew about 6.7% year-over-year against roughly 5.1% revenue growth, the operating margin decline reflects negative operating leverage as much as gross margin pressure, which typically does not self-correct without either cost action or a sales reacceleration. Excluding the weather-affected period, underlying earning power may sit closer to the mid-8% operating range, but with stock-based compensation up roughly 46% over ten quarters, adjusted figures should be treated with caution.

A DuPont-style split shows both drivers working against returns: operating margin contracted from 13.2% to 7.9% while asset turnover fell from 0.44 to 0.32 over the same span, meaning the company is earning less on each sales dollar and generating fewer sales dollars per asset dollar. With net property and equipment near 60% of a $12.3B asset base, the return profile is increasingly a function of new-store productivity, and a 2.5% ROIC sitting below any plausible cost of capital in recent years suggests the latest expansion vintage may not yet be earning its keep. The drop in ROE from 19.2% to 8.5% despite leverage rising to 2.53x is particularly telling, since borrowed capital should mechanically amplify equity returns when it is being deployed productively.

Days payable of 59 against 124 days of inventory means suppliers finance less than half the inventory position, so the working capital burden sits on the balance sheet rather than being fully passed upstream, which is consistent with the $113.6M cash absorption reported in 2026Q3. The quick ratio of 0.20 versus a current ratio of 1.38 confirms that near-term liquidity rests almost entirely on selling through inventory, so any further demand softness would translate directly into cash strain rather than just margin strain. Cash conversion cycle data is unavailable for the second-quarter periods in several of the reported years, so the quarter-over-quarter path should be read as a directional indication rather than a complete series.

Comparing like-for-like quarters, debt-to-EBITDA rose to 15.25x in 2026Q3 from 12.26x in 2025Q3 and interest coverage fell to 15.87x from 23.37x, indicating the deterioration is driven by EBITDA compression as much as by the 31% growth in total debt to $6.7B. Coverage at 15.87x still appears serviceable against any plausible coupon schedule, but the direction of travel combined with a cash balance halved to $198.9M and lowered full-year guidance leaves less room for further margin slippage. Debt maturity schedules and covenant terms were not provided in the data, so refinancing risk cannot be assessed here and warrants further investigation in the filings.